BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 32753671)

  • 21. Hierarchy of TGFβ/SMAD, Hippo/YAP/TAZ, and Wnt/β-catenin signaling in melanoma phenotype switching.
    Lüönd F; Pirkl M; Hisano M; Prestigiacomo V; Kalathur RK; Beerenwinkel N; Christofori G
    Life Sci Alliance; 2022 Feb; 5(2):. PubMed ID: 34819356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell cycle gene networks are associated with melanoma prognosis.
    Wang L; Hurley DG; Watkins W; Araki H; Tamada Y; Muthukaruppan A; Ranjard L; Derkac E; Imoto S; Miyano S; Crampin EJ; Print CG
    PLoS One; 2012; 7(4):e34247. PubMed ID: 22536322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BET inhibitor suppresses melanoma progression
    Deng G; Zeng F; Su J; Zhao S; Hu R; Zhu W; Hu S; Chen X; Yin M
    Theranostics; 2020; 10(25):11428-11443. PubMed ID: 33052224
    [No Abstract]   [Full Text] [Related]  

  • 24. The miR-31-SOX10 axis regulates tumor growth and chemotherapy resistance of melanoma via PI3K/AKT pathway.
    Zheng Y; Sun Y; Liu Y; Zhang X; Li F; Li L; Wang J
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2451-2458. PubMed ID: 29969627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PAX3 and SOX10 activate MET receptor expression in melanoma.
    Mascarenhas JB; Littlejohn EL; Wolsky RJ; Young KP; Nelson M; Salgia R; Lang D
    Pigment Cell Melanoma Res; 2010 Apr; 23(2):225-37. PubMed ID: 20067553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of meloe gene in melanomas is controlled both by specific transcription factors and hypomethylation.
    Bobinet M; Vignard V; Florenceau L; Lang F; Labarriere N; Moreau-Aubry A
    PLoS One; 2013; 8(9):e75421. PubMed ID: 24086527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systems analysis identifies miR-29b regulation of invasiveness in melanoma.
    Andrews MC; Cursons J; Hurley DG; Anaka M; Cebon JS; Behren A; Crampin EJ
    Mol Cancer; 2016 Nov; 15(1):72. PubMed ID: 27852308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.
    Shakhova O; Cheng P; Mishra PJ; Zingg D; Schaefer SM; Debbache J; Häusel J; Matter C; Guo T; Davis S; Meltzer P; Mihic-Probst D; Moch H; Wegner M; Merlino G; Levesque MP; Dummer R; Santoro R; Cinelli P; Sommer L
    PLoS Genet; 2015 Jan; 11(1):e1004877. PubMed ID: 25629959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sox10 regulates skin melanocyte proliferation by activating the DNA replication licensing factor MCM5.
    Su Z; Zheng X; Zhang X; Wang Y; Zhu S; Lu F; Qu J; Hou L
    J Dermatol Sci; 2017 Mar; 85(3):216-225. PubMed ID: 27955842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells.
    Perotti V; Baldassari P; Molla A; Nicolini G; Bersani I; Grazia G; Benigni F; Maurichi A; Santinami M; Anichini A; Mortarini R
    Oncogene; 2019 May; 38(22):4384-4396. PubMed ID: 30710146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma.
    Bakos RM; Maier T; Besch R; Mestel DS; Ruzicka T; Sturm RA; Berking C
    Exp Dermatol; 2010 Aug; 19(8):e89-94. PubMed ID: 19845757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole transcriptome analysis reveals correlation of long noncoding RNA ZEB1-AS1 with invasive profile in melanoma.
    Siena ÁDD; Plaça JR; Araújo LF; de Barros II; Peronni K; Molfetta G; de Biagi CAO; Espreafico EM; Sousa JF; Silva WA
    Sci Rep; 2019 Aug; 9(1):11350. PubMed ID: 31383874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF.
    Fane ME; Chhabra Y; Hollingsworth DEJ; Simmons JL; Spoerri L; Oh TG; Chauhan J; Chin T; Harris L; Harvey TJ; Muscat GEO; Goding CR; Sturm RA; Haass NK; Boyle GM; Piper M; Smith AG
    EBioMedicine; 2017 Feb; 16():63-75. PubMed ID: 28119061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Super-enhancers define a proliferative PGC-1α-expressing melanoma subgroup sensitive to BET inhibition.
    Gelato KA; Schöckel L; Klingbeil O; Rückert T; Lesche R; Toedling J; Kalfon E; Héroult M; Lejeune P; Mönning U; Fernández-Montalván AE; Bäurle S; Siegel S; Haendler B
    Oncogene; 2018 Jan; 37(4):512-521. PubMed ID: 28991225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptome stability profiling using 5'-bromouridine IP chase (BRIC-seq) identifies novel and functional microRNA targets in human melanoma cells.
    Joshi P; Seki T; Kitamura S; Bergano A; Lee B; Perera RJ
    RNA Biol; 2019 Oct; 16(10):1355-1363. PubMed ID: 31179855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development.
    Steunou AL; Ducoux-Petit M; Lazar I; Monsarrat B; Erard M; Muller C; Clottes E; Burlet-Schiltz O; Nieto L
    Mol Cell Proteomics; 2013 Mar; 12(3):736-48. PubMed ID: 23275444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness.
    Long E; Ilie M; Bence C; Butori C; Selva E; Lalvée S; Bonnetaud C; Poissonnet G; Lacour JP; Bahadoran P; Brest P; Gilson E; Ballotti R; Hofman V; Hofman P
    Cancer Med; 2016 Jun; 5(6):1022-30. PubMed ID: 26945789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma.
    Ramsdale R; Jorissen RN; Li FZ; Al-Obaidi S; Ward T; Sheppard KE; Bukczynska PE; Young RJ; Boyle SE; Shackleton M; Bollag G; Long GV; Tulchinsky E; Rizos H; Pearson RB; McArthur GA; Dhillon AS; Ferrao PT
    Sci Signal; 2015 Aug; 8(390):ra82. PubMed ID: 26286024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance.
    Wessely A; Steeb T; Berking C; Heppt MV
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma.
    Shakhova O; Zingg D; Schaefer SM; Hari L; Civenni G; Blunschi J; Claudinot S; Okoniewski M; Beermann F; Mihic-Probst D; Moch H; Wegner M; Dummer R; Barrandon Y; Cinelli P; Sommer L
    Nat Cell Biol; 2012 Aug; 14(8):882-90. PubMed ID: 22772081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.